REMOTE RESULTS OF USING THREE-HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES

Authors

  • Kravchun N. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Kazakov O. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0003-4774-7278
  • Romanova I. P. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Chernyavska I. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0002-4834-3972

DOI:

https://doi.org/10.21856/j-PEP.2012.4.11

Keywords:

type 2 diabetes, therapy, Tryprayd

Abstract

It was studied the consequences in patients with type 2 diabetes drug Tryprayd. These results suggest clinical efficacy of Tryprayd that can adequately control carbohydrate metabolism. During treatment, was a decrease in the level of microalbuminuria, improved lipid metabolism, stabilized body weight.

References

Тронько, М. Д. Прiоритетнi проблеми клiнiчної ендокринологiї в Українi на сучасному етапi [Текст] / М. Д. Тронько // Здоров’я України. — 2012. — № 2–3 (18–19). — С. 10–11.

Kozak, B. M. International Diabetes Federation (IDF) highlights growing global impact of diabetes in 5th edition of the Diabetes Atlas [Text] / B. M. Kozak, M. Y. Tjota, K. L. Close // Journal of Diabetes — 2012. — Vol. 4. — P. 8–17.

Чернобров, А. Д. Довiдник основних показникiв дiяльностi ендокринологiчної служби України за 2011 рiк [Текст] / А. Д. Чернобров // Ендокринологiя. — 2012. — Т. 17, № 1. — 36 с.

10-year follow-up of intensive glucose control in type 2 diabetes [Text] / R. R. Holman, S. K. Paul, M. A. Bethel [et al.] // N. Engl. J. Med. — 2008. — Vol. 359. — P. 1577–1589.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College

of Cardiology Foundation and the American Heart Association [Text] / J. S. Skyler, R. Bergenstal, J. Buse [et al.] // Diabetes Care. — 2009. — Vol. 32. — P. 187–192.

Экономика диабета и диабетической помощи [Текст] / под ред. В. Грубера, Т. Ландер, Б. Лиз [и др.]; пер. с англ. Н. Бондаренко. – М.: АРТ-БИЗНЕС-ЦЕНТР, 1999. – 128 с.

Современная терапия сахарного диабета 2 типа с использованием фармакоэкономического анализа [Текст] / Н. А. Кравчун, Ю. И. Караченцев, А. В. Казаков [и др.] // Пробл. ендокрин. патологiї — 2011, № 3. — С. 5–10.

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [Text]/ S. E. Inzucchi, R. M. Bergenstal, J. B. Buse [et al.] //Diabetes Care. — 2012. — Vol. 35. — P. 1364–1379.

UK Prospective Diabetes Study Group. Effect of intensive blood — glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS) // Lancet. — 1998. — Vol. 352. — P. 854–865.

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study [Text] / A. Neumann, A. Weill, P. Ricordeau [et al.] // Diabetologia. — 2012. — Vol. 55 (7). — P. 1953–62.

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study [Text] / J. D. Lewis, A. Ferrara, T. Peng [et al.] // Diabetes Care. — 2011. — Vol. 34. — P. 916–922.

Cohort study of pioglitazone and cancer incidence in patients with diabetes [Text] / A. Ferrara, J. D. Lewis, C. P. Quesenberry [et al.] // Diabetes Care.– 2011. — Vol. 34. — P. 923–929.

Ahmed, M. H. Current treatment of non-alcoholic fatty liver disease [Text] / M. H. Ahmed, C. D. Byrne // Diabetes Obes Metab. — 2009. — Vol. 11. — P. 188–195.

Ong, J. P. Epidemiology and natural history of NAFLD and NASH [Text] / J. P. Ong, Z. M. Younossi // Clin Liver Dis. — 2007. — Vol. 11. — P. 1–16.

Musso, G. Meta-analysis: natural history of nonalcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity [Text] / G. Musso, R. Gambino, M. Cassader, G. Pagano // Ann Med. — 2011. — Vol. 43. —

P. 617–649.

Iнструкцiя до набору реактивiв для визначення загального холестерину ферментативним методом [Текст]: утв. 21.08.02.– [Б. м.]: Фiлiсiт-Дiагностика, [б. г.]. — 4 с.

Методические указания к лабораторным работам по клинической биохимии [Текст] // Тр. Укр. ин-та усовершенствования врачей. — Харьков, 1988. — С. 62–63.

Downloads

Published

2012-12-25

How to Cite

Kravchun, N. O., Kazakov, A., Romanova, I. P., & Chernyavska, I. (2012). REMOTE RESULTS OF USING THREE-HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES . Problems of Endocrine Pathology, 42(4), 73-78. https://doi.org/10.21856/j-PEP.2012.4.11

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

<< < 1 2 3 4 > >>